Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ELV vs GSK✓SelectedUSD · GSKELV vs GSK performance historyLatest closeAs of+3.86%11/16
Stock and ETF performance explorer

ELV vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+2,671.1%
GSK return
+202.1%
Excess return
+2,469.1%
Maximum drawdown
-67.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+3.9%-0.1%+3.9%+3.9%
7D+6.7%-1.3%+8.0%+7.3%
30D+4.2%+2.7%+1.5%+2.8%
3M+12.0%+2.7%+9.3%+10.2%
6M+14.6%+3.3%+11.3%+11.9%
YTD+29.2%+6.5%+22.7%+23.0%
1Y+39.7%+10.7%+29.0%+30.6%
3Y+1.2%+64.4%-63.1%-23.8%
5Y+11.5%+46.7%-35.2%-12.6%
10Y+270.1%+109.4%+160.8%+143.5%
All+2,671.1%+202.1%+2,469.1%+1,196.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling